A new $3.3 million grant from the Bristol Myers Squibb Foundation has been awarded to the Georgia Cancer Center in an effort to impact cancer statistics for African Americans in urban and rural minority underserved areas of the state.
A group of oncologists from across the world, including Dr. Zach Klaassen of the Georgia Cancer Center, came together to develop guidelines for patients diagnosed with prostate, testicular and other genitourinary cancers during the COVID-19 pandemic.
Need an expert for your upcoming story on COVID-19? We can help.
The Georgia Cancer Center shares information for Testicular Cancer Awareness Month in its latest Facebook Live Q&A.
On a special edition of the Georgia Cancer Center Facebook Live Q&A, we discussed COVID-19 and how it can affect a cancer patient’s life.
There appears to be an unhealthy synergy between mental illness and prostate cancer, and researchers are working to dissect the relationship by first assembling the largest dataset ever of veterans with either condition or both.
MCG scientists hope non-invasive and better tests that measure a gene variant commonly found in bladder cancer could help improve patient outcomes.
No matter where students at the Medical College of Georgia are on their academic journey, it is the perfect time to find a mentor ready to help guide their career path.
Older, single white males with advanced bladder cancer have the highest suicide risk among those with other cancers of the male genitals and urinary system, researchers report. Genitourinary cancers – prostate, bladder, kidney, testis, and penile...